9
Nov
2027
Messe, Frankfurt
9 - 11 November 2027
stand 120A9

Sumitomo Chemical Europe S.A. / N.V.

About Sumitomo Chemical Europe S.A. / N.V.

Since more than 50 years, Sumitomo Chemical is a leading Japanese CDMO, known for its quality, reliability, and excellent service.  We offer regulatory starting materials, GMP intermediates, and API,  and our offering includes small molecules, peptides, and oligonucleotides.  Over the last years, Sumitomo Chemical has emerged as the world-leading commercial supplier of high-purity gRNA for genome-editing, providing unmatched purity, lead-times, analytical capabilities, and regulatory support.  Trusted by customers – trusted by regulators. 

 

 




...

Certifications

Meet us at

  • CPHI Frankfurt 2027

    Messe, Frankfurt
    9 - 11 November 2027
    stand 120A9
  • Country/Region:
    Belgium
  • Founded:
    1913
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    25 - 49
Company types
CMO/CDMO
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Contact info

Products from Sumitomo Chemical Europe S.A. / N.V. (1)

  • Oligonucleotides

    Product Oligonucleotides

    Sumitomo Chemical has unique manufacturing technology for high-purity oligonucleotides up to 400mer.  We guarantee the highest purity, the shortest lead-time to GMP production and unmatched analytical capabilities alongside strong regulatory support.  Make no compromises and work with the wor...

Sumitomo Chemical Europe S.A. / N.V. Resources (1)

  • News New cGMP commercial-scale small molecules plant

    Sumitomo Chemical has commissioned a new cGMP commercial-scale small molecules plant at its Oita site, adding new capacity to meet the growing demand of its global customer base, now offering more than 1,000m3 reactor capacity over 4 cGMP sites, guaranteeing security of supply for its new projects.   A brand-new state-of-the-art cGMP pilot plant will be opened in Osaka in fall for quick supply of the first GMP batches.